High-risk additional chromosomal abnormalities at low blast counts herald death by CML
2020 · Leukemia · 86 citations
https://doi.org/10.1038/s41375-020-0826-9
V
Volker Petersen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
57
Papers
1.3K
Citations
11
h-index
11
i10-index
Volker Petersen is an academic researcher from Praxis für Hämatologie und Onkologie. The author has contributed to research in topics: Advanced Breast Cancer Therapies & Lung Cancer Treatments and Mutations & HER2/EGFR in Cancer Research. The author has an h-index of 11, co-authored 49 publications.
Papers by this author
worksTreatment and pattern of bone metastases in 1094 patients with advanced breast cancer – Results from the prospective German Tumour Registry Breast Cancer cohort study
2017 · European Journal of Cancer · 49 citations
https://doi.org/10.1016/j.ejca.2017.03.031
Bevacizumab in first-line treatment of elderly patients with metastatic colorectal cancer: German community-based observational cohort study results
2014 · BMC Cancer · 16 citations
https://doi.org/10.1186/1471-2407-14-761
356P Real-world effectiveness in subgroups of palbociclib + endocrine therapy in HR+/HER2- ABC patients: Interim results of the PERFORM study
2024 · Annals of Oncology · 0 citations
https://doi.org/10.1016/j.annonc.2024.08.304
Treatment and outcomes of patients with HR+/HER2− early breast cancer in a real-world setting in Germany
2026 · Cancer Treatment and Research Communications · 0 citations
https://doi.org/10.1016/j.ctarc.2026.101122
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat